APLP2: Amyloid Beta Precursor Like Protein 2

A member of the amyloid precursor protein family involved in synaptic function and Alzheimer's disease-related pathways

Gene Information Card

Symbol APLP2
Full Name Amyloid Beta Precursor Like Protein 2
Gene Type protein-coding
Chromosomal Location 11q24.3
NCBI Gene ID 334 ncbi.nlm.nih.gov/gene/334
Ensembl ID ENSG00000118322
UniProt ID Q06481
OMIM ID 104776
HGNC ID 598
Aliases APLP2, APPL2, CDEBP, APLP-2

Description

APLP2 (Amyloid Beta Precursor Like Protein 2) is a member of the amyloid precursor protein (APP) family, which includes APP and APLP1. It encodes a transmembrane glycoprotein involved in synaptic adhesion, neurite outgrowth, and cell signaling. APLP2 is ubiquitously expressed and plays a role in the regulation of synaptic plasticity and neurogenesis. It is processed by secretases similar to APP, generating soluble fragments that may have neuroprotective functions. Mutations and altered expression of APLP2 have been implicated in Alzheimer's disease and certain cancers.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Alzheimer's disease APLP2 processing by gamma-secretase produces amyloidogenic fragments; altered expression may contribute to amyloid plaque formation ClinVar, OMIM
Colorectal cancer Overexpression of APLP2 promotes tumor cell proliferation and migration via MAPK/ERK signaling COSMIC, PubMed
Breast cancer APLP2 upregulation correlates with poor prognosis and metastasis through interaction with integrins COSMIC, PubMed

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.5 Medium
Lung 8.3 Low
Liver 6.1 Low
Kidney 9.7 Low
Testis 15.2 Medium
Cell Line Expression
Cell Line nTPM Notes
HEK293 10.4 Embryonic kidney cells
SH-SY5Y 14.1 Neuroblastoma cells
HepG2 7.8 Hepatocellular carcinoma cells
MCF7 11.2 Breast cancer cells
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1234G>A (p.Gly412Arg) Missense <0.1% Altered protein processing; potential loss of function
c.567C>T (p.Pro189Leu) Missense <0.1% Unknown functional effect
c.890_892del (p.Glu297del) In-frame deletion <0.1% May affect synaptic adhesion
Mutation functional classification

Loss of Function (LOF)

Rare missense variants (e.g., p.Gly412Arg) may impair protein stability or processing, reducing normal synaptic function.

Gain of Function (GOF)

Overexpression in cancer cells suggests potential gain-of-function in tumorigenesis, but specific activating mutations are not well characterized.

Dominant Negative (DN)

No dominant-negative mutations have been reported for APLP2.

Gene Ontology (GO)

• synaptic adhesion • neurite outgrowth
• cell adhesion • protein processing
• signal transduction

Pathways

Alzheimer's disease - presenilin pathway
APP processing by gamma-secretase
Integrin signaling pathway

Protein Summary

APLP2 is a type I transmembrane glycoprotein of 763 amino acids, belonging to the APP family. It contains a large extracellular domain with E1 and E2 subdomains, a Kunitz-type protease inhibitor (KPI) domain, and a short cytoplasmic tail with a YENPTY motif involved in endocytosis and signaling. The protein is cleaved by alpha-, beta-, and gamma-secretases, generating soluble N-terminal fragments and a C-terminal fragment that may be further processed. APLP2 is widely expressed in neural and non-neural tissues, where it mediates cell-cell adhesion, neurite outgrowth, and synaptic plasticity. Its structure and processing are similar to APP, but it lacks the amyloid beta peptide region, thus not directly contributing to amyloid plaque formation.

Related Products

Product name Cat.No. Species Gene ID
APLP2 Knockout HEK293 Cell Line EDJ-KQ4065 Human 334 Details Get a Quote
APLP2 Knockout A-549 Cell Line EDJ-KQ26434 Human 334 Details Get a Quote
APLP2 Knockout HCT 116 Cell Line EDJ-KQ26435 Human 334 Details Get a Quote
APLP2 Knockout HeLa Cell Line EDJ-KQ26436 Human 334 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: